Fang Li
Impact in
- Cancer Research top 1%
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
- Molecular Biology top 5%
- Cell death mechanisms and regulation
- Circular RNAs in diseases
Papers in
-
- Cancer-related molecular mechanisms research 26
- MicroRNA in disease regulation 12
- NF-κB Signaling Pathways 6
- Epidemiology 19
- Cervical Cancer and HPV Research 16
- Co-authors
- Chuan‐Yuan Li (7 shared papers)Qian Huang (5 shared papers)Mark W. Dewhirst (4 shared papers)Zahid N. Rabbani (3 shared papers)Bin Yan (2 shared papers)Wenrong Li (3 shared papers)Željko Vujašković (2 shared papers)Xinjian Liu (2 shared papers)
- Journals
- Journal of Biological Chemistry (4 papers)Frontiers in Genetics (3 papers)Cancer Research (3 papers)Frontiers in Oncology (3 papers)Molecular Therapy — Nucleic Acids (2 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Fang Li
135 papers receiving 4.7k citations
Fang Li's Hit Papers
Peers
Comparison fields: 5 of 119
- Cancer Research 1k
- Molecular Biology 1.5k
- Oncology 503
- Nephrology 202
- Immunology 255
Countries citing papers authored by Fang Li
This map shows the geographic impact of Fang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fang Li more than expected).
Fields of papers citing papers by Fang Li
This network shows the impact of papers produced by Fang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fang Li. The network helps show where Fang Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Fang Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 145 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Caspase 3–mediated stimulation of tumor cell repopulation during cancer radiotherapy Hit paper breakdown → | 2011 | 757 |
| 2 | 2007 | 391 | |
| 3 | 2018 | 327 | |
| 4 | 2019 | 196 | |
| 5 | 2012 | 187 | |
| 6 | 2006 | 145 | |
| 7 | 2019 | 130 | |
| 8 | 2020 | 123 | |
| 9 | 2005 | 109 | |
| 10 | 2004 | 108 | |
| 11 | 2009 | 82 | |
| 12 | 2017 | 80 | |
| 13 | 2019 | 71 | |
| 14 | 2020 | 70 | |
| 15 | 2017 | 62 | |
| 16 | 2022 | 62 | |
| 17 | 2013 | 54 | |
| 18 | 2010 | 51 | |
| 19 | 2018 | 51 | |
| 20 | 2024 | 50 |
About Fang Li
Fang Li is a scholar working on Cancer Research, Epidemiology, Molecular Biology, Oncology and Pulmonary and Respiratory Medicine, having authored 145 papers that have together received 4.8k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (26 papers), Cervical Cancer and HPV Research (16 papers), MicroRNA in disease regulation (12 papers), NF-κB Signaling Pathways (6 papers), Gastric Cancer Management and Outcomes (4 papers), Cell death mechanisms and regulation (4 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Mechanisms of cancer metastasis (3 papers). The work is most often cited by research in Cancer Research (1k citations), Molecular Biology (1.5k citations), Oncology (503 citations), Nephrology (202 citations) and Immunology (255 citations). Fang Li has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Chuan‐Yuan Li, Qian Huang, Mark W. Dewhirst, Zahid N. Rabbani, Bin Yan, Wenrong Li, Željko Vujašković, Xinjian Liu, Pierre Sonveaux and Shanling Liu. Their work appears in journals such as Journal of Biological Chemistry, Frontiers in Genetics, Cancer Research, Frontiers in Oncology and Molecular Therapy — Nucleic Acids.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.